Pharmacom Biovet Stock Buy Hold or Sell Recommendation
| PHMB Stock | USD 0.0001 0.00 0.00% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Pharmacom Biovet is 'Strong Sell'. Macroaxis provides Pharmacom Biovet buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding PHMB positions.
Check out Pharmacom Biovet Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Pharmacom Stock refer to our How to Trade Pharmacom Stock guide. In addition, we conduct extensive research on individual companies such as Pharmacom and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Pharmacom Biovet. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Pharmacom |
Execute Pharmacom Biovet Buy or Sell Advice
The Pharmacom recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Pharmacom Biovet. Macroaxis does not own or have any residual interests in Pharmacom Biovet or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Pharmacom Biovet's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Pharmacom Biovet Trading Alerts and Improvement Suggestions
| Pharmacom Biovet generated a negative expected return over the last 90 days | |
| Pharmacom Biovet has some characteristics of a very speculative penny stock | |
| Pharmacom Biovet has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (556.18 K) with profit before overhead, payroll, taxes, and interest of 0. |
Pharmacom Biovet Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Pharmacom Biovet or Health Care Providers & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Pharmacom Biovet's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Pharmacom stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Pharmacom Biovet Volatility Alert
At this time Pharmacom Biovet exhibits very low volatility. Pharmacom Biovet appears to be a penny stock. Although Pharmacom Biovet may be, in fact, a solid short-term or long term investment, many penny stocks are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in Pharmacom Biovet or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Pharmacom instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Pharmacom Biovet Fundamentals Vs Peers
Comparing Pharmacom Biovet's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Pharmacom Biovet's direct or indirect competition across all of the common fundamentals between Pharmacom Biovet and the related equities. This way, we can detect undervalued stocks with similar characteristics as Pharmacom Biovet or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Pharmacom Biovet's fundamental indicators could also be used in its relative valuation, which is a method of valuing Pharmacom Biovet by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Pharmacom Biovet to competition |
| Fundamentals | Pharmacom Biovet | Peer Average |
| Current Valuation | 1.08 M | 16.62 B |
| Net Income | (556.18 K) | 570.98 M |
| Total Debt | 61.54 K | 5.32 B |
| Beta | 168.8 | -0.15 |
| Market Capitalization | 1.08 M | 19.03 B |
| Total Asset | 112.36 K | 29.47 B |
| Retained Earnings | (19.05 M) | 9.33 B |
| Working Capital | (29 K) | 1.48 B |
| Current Liabilities | 29 K | 7.9 B |
| Net Asset | 112.36 K |
Pharmacom Biovet Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Pharmacom . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
About Pharmacom Biovet Buy or Sell Advice
When is the right time to buy or sell Pharmacom Biovet? Buying financial instruments such as Pharmacom Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Pharmacom Biovet in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Equity ETFs Thematic Idea Now
Broad Equity ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Equity ETFs theme has 479 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Equity ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Pharmacom Biovet Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Pharmacom Stock refer to our How to Trade Pharmacom Stock guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pharmacom Biovet. If investors know Pharmacom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pharmacom Biovet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Pharmacom Biovet is measured differently than its book value, which is the value of Pharmacom that is recorded on the company's balance sheet. Investors also form their own opinion of Pharmacom Biovet's value that differs from its market value or its book value, called intrinsic value, which is Pharmacom Biovet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pharmacom Biovet's market value can be influenced by many factors that don't directly affect Pharmacom Biovet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pharmacom Biovet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pharmacom Biovet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pharmacom Biovet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.